Evinova

Name

Evinova

Legal name

Evinova AG

Website

https://evinova.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Clinical Trial Technology

NAICS

Computer Systems Design Services (541512), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)

akta.pro industry

PRIMARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLACAOAJ

Site & Investigator Platforms (Site Payments, Feasibility, Activation)

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

SECONDARYHLACAOAB

eCOA/ePRO/eDiary & Patient-Facing Data Collection

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

• Clinical trial technology
• Digital health platforms
• Decentralized clinical trials
• AI clinical development
• Pharmaceutical software solutions

Headquarters

HQ city

Baar

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. AI-Native Platform Licensing: Enterprise software licensing of AI-native clinical development platform including Study Designer, Portfolio Management, and Unified Trial Solution modules. Platform has delivered hundreds of millions of dollars in multi-year savings for customers.
2. Cost Optimizer Module: Deployment of Cost Optimizer module of Study Designer across global portfolios, generating efficiency and cost reduction for pharma customers.
3. Consulting Services: Digital strategy consulting, regulatory consulting, evidence strategy, and endpoint validation services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Evinova sells an AI-native clinical development platform that helps pharmaceutical companies, biotechs, and CROs design, plan, execute, and monitor clinical trials more efficiently. The platform includes the Unified Trial Solution for decentralized trial operations, Study Design & Optimization (Study Designer) with a Cost Optimizer module, Portfolio Management with predictive analytics, Study Document Assistant, and Remote Patient Monitoring, complemented by Digital Strategy Consulting services and Carbon Estimation & Reporting. Customers subscribe to enterprise licenses of these modular solutions and engage Evinova's consulting team for digital health strategy, regulatory, and evidence-generation support.

Product overview

Evinova offers a modular, AI-native clinical development platform comprising core products (Unified Trial Solution, Study Design & Optimization, Portfolio Management) within the Drug Development Suite, supplemented by specialized AI modules (AI Authoring, AI Digitizer, Cost Optimizer, Study Document Assistant), Remote Patient Monitoring capabilities, and strategic consulting services. The platform enables end-to-end clinical trial optimization from study design through execution, delivering proven outcomes including 60% improvement in patient experience, 32% cost reduction, and 6-month acceleration in trial delivery. Evinova operates as a separate health-tech business within the AstraZeneca Group, combining pharmaceutical expertise with AI-enabled digital solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Study Designer: AI-native solution for clinical study design, optimization, costing, and benchmarking. Empowers clinical teams to design smarter, faster, and more cost-effective studies in minutes.
• Unified Trial Solution (UTS)
• Portfolio Management
• Study Document Assistant (SDA)
• Remote Patient Monitoring (RPM)
• Drug Development Suite

Products and services

• AI Platform End-to-end AI-enabled clinical development platform that streamlines operations, reduces burden, and drives faster decision-making across the clinical trial lifecycle through modular solutions including Study Design & Optimization, Portfolio Management, and Digital Trial Solutions, built on multi-tenant SaaS architecture with TLS 1.3 encryption and SAML 2.0 / OAuth 2.0 SSO.
• Unified Trial Solution (UTS) All-in-one digital clinical trial management platform connecting patients, investigative sites, and sponsors through a single integrated experience supporting decentralized trials, remote monitoring, eCOA, telehealth, and real-time data capture; supports 74% of assessments from home and reduces in-person clinical visits by up to 40%.
• Study Design & Optimization (Study Designer) AI-native study design and planning solution enabling teams to design optimal clinical studies in minutes with capabilities for cost estimation (97%+ accuracy), scenario comparison across cost, timelines, patient experience, and carbon emissions, feasibility assessment, protocol digitization, and accelerated authoring; integrates with Citeline's Sitetrove and Trialtrove intelligence databases.
• Portfolio Management Portfolio tracking and management solution providing real-time visibility into financial and clinical performance with AI-powered predictive recruitment curves at 94% accuracy, comparison against internal and external benchmarks, and proactive alerts identifying at-risk trials with recommended next-best actions.
• Drug Development Suite Umbrella product combining Study Design & Planning and Pipeline Management modules to increase transparency across the portfolio and empower decision-making at every level of the organization, providing end-to-end clinical development support across study design through execution.
• Study Document Assistant (SDA) AI-powered document navigation solution that simplifies clinical documentation workflows using a custom-trained AI model, reducing query resolution time by 80%, protocol amendment identification time by 50%, and health authority response time by 70% for clinical operations teams.
• Digital Strategy Consulting Expert-led consulting services blending deep scientific expertise with digital strategy including digital health strategy across therapy areas, regulatory consulting with global submission readiness, AI-powered patient recruitment cutting timelines by up to a year, and evidence-driven access and endpoint validation for life sciences sponsors.
• Recruitment by Design Digitally optimized patient recruitment service using AI and EHR analytics for precision-matched referrals, real-time funnel analytics, and conversion rates 4-5x higher than other digital recruitment methods, designed to cut recruitment timelines by up to a year.
• Carbon Estimation & Reporting End-to-end carbon emissions reporting and reduction solution for clinical trials including consulting services and a study design module with real-time carbon estimation and reduction recommendations, helping sponsors meet sustainability targets within clinical development.

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered minor, core, flagship and regional.

• Tufts Center for the Study of Drug DevelopmentminorStrategic or Co-development Partner · 22 June 2026Research partnership with Tufts CSDD on digital tool adoption among investigative sites. Joint research study on how clinical research sites are investing in and using digital tools, with findings to be published.
• CitelinecoreTechnology or Integration · 26 February 2026Multi-year partnership integrating Citeline's clinical trial intelligence databases (Sitetrove with 500,000+ investigators and 190,000 trial sites; Trialtrove with curated real-world trial intelligence) into Evinova's AI-native Study Designer platform for data-driven optimization of clinical study design.
• Astellas PharmaflagshipStrategic or Co-development Partner · 18 February 2026Strategic collaboration where Astellas deploys Evinova's AI-native Study Designer platform to design smarter, more patient-centered studies, eliminate avoidable rework, and move with greater speed and precision in R&D. Partners share operational data with Evinova for benchmarking.
• AstraZenecaflagshipStrategic or Co-development Partner · 18 February 2026AstraZeneca continues collaboration with Evinova to harness AI for accelerating clinical development, improving productivity gains, delivering faster trials, and enhancing patient experience. Strategic collaboration reflects strong industry demand for AI-native platforms built specifically for clinical development.
• Bristol Myers SquibbflagshipStrategic or Co-development Partner · 18 February 2026BMS partners with Evinova to deploy the Cost Optimizer module of Study Designer across its global portfolio, leveraging advanced AI to improve insight-driven decision-making, identify productivity opportunities, and unlock more efficient trial designs.
• Harbour BioMedregionalStrategic or Co-development Partner · 7 November 2025Evinova China and Harbour BioMed announced strategic AI collaboration during CIIE to jointly apply AI and digital technologies to enhance efficiency of innovative biologics development and build an open ecosystem for AI-driven drug R&D.
• Quantum Leap Healthcare CollaborativecoreStrategic or Co-development Partner · 20 March 2025Partnership to incorporate Evinova's Remote Patient Monitoring solution into I-SPY 2.2 breast cancer platform trial. RPM module monitors patients at risk of developing interstitial lung disease from treatments, enabling early identification and intervention.
• ParexelcoreChannel Partner/ Reseller/ Distributor · 20 November 2023First strategic collaboration with globally-leading CRO Parexel to offer Evinova's digital health solutions to their wide customer base, accelerating industry adoption.
• FortreacoreChannel Partner/ Reseller/ Distributor · 20 November 2023First strategic collaboration with globally-leading CRO Fortrea to offer Evinova's digital health solutions to their wide customer base, accelerating industry adoption.
• AccentureminorImplementation/ SI/ Consulting Partner · 20 November 2023Collaboration with Accenture to accelerate industry adoption and sustain and expand the global reach of Evinova's digital products.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Largest CRO with broad digital clinical trial capabilities and proprietary technology platforms. Comparable as a broad incumbent offering overlapping clinical development technology and services at scale.

Emerging players

• Science 37: Decentralized clinical trial operator with proprietary patient-facing technology. Comparable as an emerging player in decentralized trial delivery, addressing similar pharma sponsors with remote-first trial designs.
• Saama Technologies: AI-driven clinical development analytics platform focused on trial operations and data insights. Comparable as an emerging AI-focused player addressing pharma clinical operations with predictive analytics similar to Evinova's Portfolio Management.
• Medable: Decentralized clinical trial platform with eCOA, telehealth, and eConsent. Comparable to Evinova's UTS decentralized trial capabilities, with similar focus on remote patient monitoring and digital endpoints.
• ArisGlobal: Life sciences platform provider with clinical trial, safety, and regulatory solutions including CTMS, EDC, and pharmacovigilance. Comparable as an emerging player with a broader life sciences R&D platform strategy.
• Castor: Cloud-based EDC and ePRO platform with focus on mid-market and academic sponsors. Comparable as an emerging EDC/eCOA competitor with modern, API-first architecture.

Direct peers

• Medidata (Dassault Systèmes): Industry-leading clinical trial platform (Rave EDC, eCOA, RTSM, CTMS) serving pharma and CROs. Directly comparable as a comprehensive clinical trial informatics platform competing for the same enterprise pharma sponsors.
• Oracle Clinical One: Oracle's unified clinical trial platform covering EDC, RTSM, eCOA, and patient engagement. Direct competitor for enterprise pharma platform deals with similar end-to-end trial scope.
• Clario: Specializes in eCOA, cardiac safety, and imaging for clinical trials. Directly comparable for the eCOA, telehealth, and connected device modules within Evinova's Unified Trial Solution.
• Veeva Systems: Life sciences cloud platform with Vault CTMS, Vault eTMF, and SiteVault. Directly comparable across clinical trial management and site operations, with Evinova already integrating with Veeva.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/evinova

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evinova